Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Non-Current Deffered Revenue (2016 - 2025)

Macrogenics (MGNX) has disclosed Non-Current Deffered Revenue for 14 consecutive years, with $55.5 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue changed 0.0% to $55.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $55.5 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $55.5 million for FY2025, 0.0% changed from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $55.5 million at Macrogenics, down from $55.8 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $64.3 million in Q3 2023, with the low at $7.3 million in Q1 2021.
  • Average Non-Current Deffered Revenue over 5 years is $49.8 million, with a median of $55.9 million recorded in 2025.
  • The sharpest move saw Non-Current Deffered Revenue soared 690.63% in 2022, then fell 13.63% in 2024.
  • Over 5 years, Non-Current Deffered Revenue stood at $9.6 million in 2021, then surged by 521.2% to $59.5 million in 2022, then decreased by 0.4% to $59.2 million in 2023, then decreased by 6.31% to $55.5 million in 2024, then changed by 0.0% to $55.5 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $55.5 million, $55.8 million, and $55.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.